Clinical Research Directory
Browse clinical research sites, groups, and studies.
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study
Sponsor: Novartis Pharmaceuticals
Summary
This study aims to address several key questions regarding the use of inclisiran in real-world clinical practice in Spain.
Official title: An Observational Prospective Study to Assess the Effectiveness of Inclisiran(Leqvio®)in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spanish Clinical Practice:the INSPIRE Study
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2025-06-16
Completion Date
2027-05-01
Last Updated
2026-02-20
Healthy Volunteers
No
Interventions
Inclisiran
This is an observational study, there is no treatment allocation.
Locations (19)
Novartis Investigative Site
Cadiz, Andalusia, Spain
Novartis Investigative Site
Granada, Andalusia, Spain
Novartis Investigative Site
Huelva, Andalusia, Spain
Novartis Investigative Site
Jaén, Andalusia, Spain
Novartis Investigative Site
Marbella, Andalusia, Spain
Novartis Investigative Site
Puerto Real, Cadiz, Spain
Novartis Investigative Site
Santander, Cantabria, Spain
Novartis Investigative Site
Andújar, Jaen, Spain
Novartis Investigative Site
Logroño, La Rioja, Spain
Novartis Investigative Site
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain
Novartis Investigative Site
Burgos, Spain
Novartis Investigative Site
Córdoba, Spain
Novartis Investigative Site
Fuerteventura, Spain
Novartis Investigative Site
Las Palmas GC, Spain
Novartis Investigative Site
León, Spain
Novartis Investigative Site
Málaga, Spain
Novartis Investigative Site
Salamanca, Spain
Novartis Investigative Site
Seville, Spain
Novartis Investigative Site
Seville, Spain